A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 252 participants.
Also called NCT01977573
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 252 participants
- Sponsor
- Registry
-
NCT01977573
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Australia, Canada, Czechia, Denmark, France, Germany, Hungary, Japan, Poland, Russia, South Korea, Spain, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01977573. Randomized; single masking; primary purpose treatment. Start 2013-10-31 (registry gives no type); primary completion 2015-05-01 (actual). Results posted on 2016-06-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
- Condition
- Anaemia
- Intervention (Drug)
- GSK1278863
- Intervention (Drug)
- rhEPO
- Lead sponsor
- GlaxoSmithKline
Record details
- Record id
cardio:ct-nct01977573- Content hash
6634dc5139d2ea3b4cfb53e80740b4a16def11739b43b2764ad87f967c294e48